Restart Life Sciences Insider Trading
CSE HEAL
4
All Trades
2
Significant
2
Notable
0
Clusters
4
Repeat
Healthcare
Sector
Biotechnology
Industry
$4.3M
Market Cap
0.07 – 0.14
52 Week Range
71K
Avg. Volume
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Restart Life Sciences | Harrycharran, Khavita | Director | 17-Mar-26 | 2,463,808 | NT RP | ||||
| Restart Life Sciences | Harrycharran, Khavita | Director | 16-Mar-26 | 2,063,808 | NT RP | ||||
| Restart Life Sciences | Harrycharran, Khavita | Director | 10-Dec-25 | 1,813,808 | SI RP | ||||
| Restart Life Sciences | Harrycharran, Khavita | Director | 09-Dec-25 | 935,004 | SI RP |
Restart Life Sciences (HEAL): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Restart Life Sciences Corp. is a Canadian biotechnology company that operates through subsidiaries in two main areas: the research and development of psilocybin, and the funding of food-related research to support a portfolio of consumer health and wellness products. The company collaborates with the University of Manitoba’s Richardson Centre for Food Technology and Research to conduct a series of food-related scientific studies. This work spans multiple product lines, including BrainQ, BrainBalls, and Holy Crap. Restart Life Sciences Corp. was previously known as Nova Mentis Life Science Corp. and adopted its current name in November 2024. The company is incorporated and based in Vancouver, Canada, and was founded in 2004. It operates within the healthcare sector, specifically in the biotechnology industry.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.